The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Real-world comparative economics of a 12-gene assay for prognosis in stage II colon cancer.
Tiffany Yu
Research Funding - Genomic Health
Steven R. Alberts
No relevant relationships to disclose
Robert J. Behrens
No relevant relationships to disclose
Lindsay A. Renfro
No relevant relationships to disclose
Geetika Srivastava
No relevant relationships to disclose
Gamini S. Soori
No relevant relationships to disclose
Shaker R. Dakhil
No relevant relationships to disclose
Rex B. Mowat
No relevant relationships to disclose
J. Phillip Kuebler
No relevant relationships to disclose
George P. Kim
No relevant relationships to disclose
Miroslaw Mazurczak
No relevant relationships to disclose
John C. Hornberger
Research Funding - Crescendo Bioscience; Genentech; GenomeDx; Genomic Health; Jefferson Medical School; Lilly; Novo Nordisk; Pathwork Diagnostics; Quest; Rockefeller Foundation